MCCORMICK FRANK
Insider CIK 1257809 · ADRO Director · BBIO Chairman of Oncology, Director · OLMA Director · BBOT Director · EXEL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2026-06-22 | 2026-06-24 | 5,277 | — | $0 | 5,277 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2026-06-22 | 2026-06-24 | 3,990 | — | $0 | 10,579 | SEC↗ |
| BBOT BridgeBio Oncology Therape | A Award deriv | 2026-06-16 | 2026-06-18 | 31,675 | — | $0 | 31,675 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-10-29 | 2025-10-31 | 3,497 | $67.52 | $236.1K | 731,970 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-10-29 | 2025-10-31 | 8,598 | $68.50 | $589.0K | 723,372 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-10-29 | 2025-10-31 | 43,393 | $69.24 | $3.00M | 679,979 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-10-29 | 2025-10-31 | 31,116 | $66.20 | $2.06M | 735,467 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-10-29 | 2025-10-31 | 111,755 | $65.48 | $7.32M | 766,583 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-10-27 | 2025-10-29 | 1,641 | $65.00 | $106.7K | 878,338 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-09-05 | 2025-09-08 | 74,000 | — | $0 | 84,814 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2025-09-05 | 2025-09-08 | 74,000 | $11.92 | $882.1K | 157,275 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-09-05 | 2025-09-08 | 74,000 | $53.16 | $3.93M | 83,275 | SEC↗ |
| BBOT BridgeBio Oncology Therape | A Award deriv | 2025-08-26 | 2025-08-28 | 91,076 | — | $0 | 91,076 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-06-24 | 2025-06-26 | 100,000 | $44.23 | $4.42M | 879,979 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2025-06-20 | 2025-06-24 | 8,425 | — | $0 | 8,425 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2025-06-20 | 2025-06-24 | 6,589 | — | $0 | 83 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | G Gift | 2025-05-08 | 2025-05-09 | 3,000 | — | $0 | 76,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | G Gift | 2025-05-07 | 2025-05-09 | 33,000 | — | $0 | 79,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | G Gift | 2024-12-26 | 2025-01-08 | 7,400 | — | $0 | 112,686 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | G Gift | 2024-12-26 | 2024-12-27 | 7,400 | — | $0 | 464,976 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2024-06-21 | 2024-06-25 | 26,014 | — | $0 | 26,014 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-12-26 | 2023-12-28 | 100,000 | $42.06 | $4.21M | 627,689 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2023-02-21 | 2023-02-23 | 158,814 | — | $0 | 158,814 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion deriv | 2020-11-23 | 2020-11-23 | 66,326 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion deriv | 2020-11-23 | 2020-11-23 | 152,891 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion | 2020-11-23 | 2020-11-23 | 152,891 | — | $0 | 191,113 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion | 2020-11-23 | 2020-11-23 | 66,326 | — | $0 | 84,260 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2020-11-18 | 2020-11-19 | 21,520 | — | $0 | 21,520 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-11-13 | 2020-11-17 | 10,069 | $43.57 | $438.7K | 1,200,468 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-11-13 | 2020-11-17 | 58,299 | $42.91 | $2.50M | 1,210,537 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-11-13 | 2020-11-17 | 31,632 | $42.22 | $1.34M | 1,268,836 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2020-09-18 | 2020-11-19 | 56,964 | — | $0 | 56,964 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 10,549 | — | $0 | 10,549 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2020-05-19 | 2020-05-21 | 39,042 | — | $0 | 1,300,568 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2019-12-30 | 2019-12-31 | 900 | $36.86 | $33.2K | 1,261,526 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2019-12-30 | 2019-12-31 | 16,250 | $35.74 | $580.8K | 1,262,426 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2019-12-27 | 2019-12-31 | 25,531 | $36.37 | $928.6K | 1,335,895 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2019-12-27 | 2019-12-31 | 21,656 | $36.85 | $798.0K | 1,314,239 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2019-12-27 | 2019-12-31 | 3,500 | $38.09 | $133.3K | 1,310,739 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2019-12-27 | 2019-12-31 | 13,705 | $39.27 | $538.2K | 1,297,034 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2019-12-27 | 2019-12-31 | 16,858 | $40.13 | $676.5K | 1,280,176 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2019-12-27 | 2019-12-31 | 883 | $41.31 | $36.5K | 1,279,293 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2019-12-27 | 2019-12-31 | 617 | $42.26 | $26.1K | 1,278,676 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2019-12-27 | 2019-12-31 | 100 | $42.93 | $4.3K | 1,278,576 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 290,476 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 418,016 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 47,165 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 406,723 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 66,729 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2019-07-01 | 2019-07-03 | 132,317 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 47,165 | — | $0 | 47,165 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 132,317 | — | $0 | 179,482 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 66,729 | — | $0 | 246,211 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 406,723 | — | $0 | 652,934 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 418,016 | — | $0 | 1,070,950 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2019-07-01 | 2019-07-03 | 290,476 | — | $0 | 1,361,426 | SEC↗ |
| ADRO ADURO BIOTECH, INC. | A Award deriv | 2018-06-06 | 2018-06-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ADRO ADURO BIOTECH, INC. | A Award deriv | 2017-06-08 | 2017-06-12 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ADRO ADURO BIOTECH, INC. | A Award deriv | 2016-06-09 | 2016-06-10 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ADRO ADURO BIOTECH, INC. | A Award deriv | 2015-04-14 | 2015-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2013-12-06 | 2013-12-09 | 66,070 | — | $0 | 66,070 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2013-05-23 | 2013-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EXEL EXELIXIS INC | A Award deriv | 2012-05-24 | 2012-05-25 | 15,000 | — | $0 | 15,000 | SEC↗ |